Vektor Medical Receives FDA 510(k) Clearance Adding Atrial Flutter Mapping, Enhanced Connectivity and New Integration Capabilities to Next-Generation vMap Clearance Expands vMap’s Non-Invasive Mapping ...
Visit Vektor Medical at Booth 208 to Learn More about vMap®, the VITAL-EP Registry’s AF Findings, and the Newly Released Atrial Flutter Workflow At this year’s meeting, a featured study titled "High ...
Please provide your email address to receive an email when new articles are posted on . Acutus Medical announced that its suite of new algorithms for the mapping and ablation of complex atrial ...
Boston Scientific announced that the FDA approved two navigation-enabled ablation catheters for treatment of type I atrial flutter. The magnetically tracked catheters (IntellaNav XP and IntellaNav ...
Clinical and demographic characteristics before catheter ablation, as well as data and follow-up outcome, have been prospectively collected in 105 patients with paroxysmal/persistent AF, including 40 ...
Catheter ablation is less successful for persistent atrial fibrillation than for paroxysmal atrial fibrillation. Guidelines suggest that adjuvant substrate modification in addition to pulmonary-vein ...
Vektor Medical to Showcase VITAL-EP Registry’s Atrial Fibrillation Results, Including Fast, Zero-Fluoro PVI+ Ablation Workflow, and New Atrial Flutter Capabilities Visit Vektor Medical at Booth 208 to ...
Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced its participation in AF Symposium 2026, taking place February 5–8 in Boston, where new clinical data ...